KRAS and neoplasm: Cancer sufferer characteristics are reported in Table 1, covering clinical efficacy, age, gender, ECOG PS, smoking and alcohol-drinking history, first-degree relative cancer history, differentiation grade, stage, tumor location, differentiation grade, KRAS status and chemotherapy regimens and response to treatment.